If you have latent tuberculosis, you may need to take only one or two types of TB drug. Active tuberculosis, particularly if it's a drug-resistant strain, will require several drugs at once. The most common medications used to treat tuberculosis include:

Isoniazid

Rifampin (Rifadin, Rimactane)

Ethambutol (Myambutol)

Pyrazinamide

Market Analysis and Insights: Global Tuberculosis (TB) Treatment Market

The global Tuberculosis (TB) Treatment market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Tuberculosis (TB) Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Tuberculosis (TB) Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Tuberculosis (TB) Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tuberculosis (TB) Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Tuberculosis (TB) Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Tuberculosis (TB) Treatment revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Tuberculosis (TB) Treatment Market Report

Report Metric	Details
Report Name	Tuberculosis (TB) Treatment Market
CAGR	5%
Segment by Type	Isoniazid Rifampin (Rifadin, Rimactane) Ethambutol (Myambutol) Pyrazinamide
Segment by Application	Active TB Latent TB
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Johnson & Johnson, Otsuka Pharmaceutical Co., Ltd, Macleods Pharmaceutical Ltd, Dong-A ST Co., Ltd, Lupin Ltd, Janssen Products, LP, Mylan, Sanofi
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Tuberculosis (TB) Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tuberculosis (TB) Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tuberculosis (TB) Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Tuberculosis (TB) Treatment Market report?

Ans: The main players in the Tuberculosis (TB) Treatment Market are Johnson & Johnson, Otsuka Pharmaceutical Co., Ltd, Macleods Pharmaceutical Ltd, Dong-A ST Co., Ltd, Lupin Ltd, Janssen Products, LP, Mylan, Sanofi

What are the Application segmentation covered in the Tuberculosis (TB) Treatment Market report?

Ans: The Applications covered in the Tuberculosis (TB) Treatment Market report are Active TB, Latent TB

What are the Type segmentation covered in the Tuberculosis (TB) Treatment Market report?

Ans: The Types covered in the Tuberculosis (TB) Treatment Market report are Isoniazid, Rifampin (Rifadin, Rimactane), Ethambutol (Myambutol), Pyrazinamide

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Tuberculosis (TB) Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Isoniazid

1.2.3 Rifampin (Rifadin, Rimactane)

1.2.4 Ethambutol (Myambutol)

1.2.5 Pyrazinamide

1.3 Market by Application

1.3.1 Global Tuberculosis (TB) Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Active TB

1.3.3 Latent TB

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tuberculosis (TB) Treatment Market Perspective (2019-2030)

2.2 Global Tuberculosis (TB) Treatment Growth Trends by Region

2.2.1 Tuberculosis (TB) Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Tuberculosis (TB) Treatment Historic Market Size by Region (2019-2024)

2.2.3 Tuberculosis (TB) Treatment Forecasted Market Size by Region (2025-2030)

2.3 Tuberculosis (TB) Treatment Market Dynamics

2.3.1 Tuberculosis (TB) Treatment Industry Trends

2.3.2 Tuberculosis (TB) Treatment Market Drivers

2.3.3 Tuberculosis (TB) Treatment Market Challenges

2.3.4 Tuberculosis (TB) Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Tuberculosis (TB) Treatment by Players

3.1.1 Global Tuberculosis (TB) Treatment Revenue by Players (2019-2024)

3.1.2 Global Tuberculosis (TB) Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Tuberculosis (TB) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Tuberculosis (TB) Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Tuberculosis (TB) Treatment Market Concentration Ratio

3.4.1 Global Tuberculosis (TB) Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis (TB) Treatment Revenue in 2023

3.5 Global Key Players of Tuberculosis (TB) Treatment Head office and Area Served

3.6 Global Key Players of Tuberculosis (TB) Treatment, Product and Application

3.7 Global Key Players of Tuberculosis (TB) Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Tuberculosis (TB) Treatment Breakdown Data by Type

4.1 Global Tuberculosis (TB) Treatment Historic Market Size by Type (2019-2024)

4.2 Global Tuberculosis (TB) Treatment Forecasted Market Size by Type (2025-2030)

5 Tuberculosis (TB) Treatment Breakdown Data by Application

5.1 Global Tuberculosis (TB) Treatment Historic Market Size by Application (2019-2024)

5.2 Global Tuberculosis (TB) Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Tuberculosis (TB) Treatment Market Size (2019-2030)

6.2 North America Tuberculosis (TB) Treatment Market Size by Type

6.2.1 North America Tuberculosis (TB) Treatment Market Size by Type (2019-2024)

6.2.2 North America Tuberculosis (TB) Treatment Market Size by Type (2025-2030)

6.2.3 North America Tuberculosis (TB) Treatment Market Share by Type (2019-2030)

6.3 North America Tuberculosis (TB) Treatment Market Size by Application

6.3.1 North America Tuberculosis (TB) Treatment Market Size by Application (2019-2024)

6.3.2 North America Tuberculosis (TB) Treatment Market Size by Application (2025-2030)

6.3.3 North America Tuberculosis (TB) Treatment Market Share by Application (2019-2030)

6.4 North America Tuberculosis (TB) Treatment Market Size by Country

6.4.1 North America Tuberculosis (TB) Treatment Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Tuberculosis (TB) Treatment Market Size by Country (2019-2024)

6.4.3 North America Tuberculosis (TB) Treatment Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Tuberculosis (TB) Treatment Market Size (2019-2030)

7.2 Europe Tuberculosis (TB) Treatment Market Size by Type

7.2.1 Europe Tuberculosis (TB) Treatment Market Size by Type (2019-2024)

7.2.2 Europe Tuberculosis (TB) Treatment Market Size by Type (2025-2030)

7.2.3 Europe Tuberculosis (TB) Treatment Market Share by Type (2019-2030)

7.3 Europe Tuberculosis (TB) Treatment Market Size by Application

7.3.1 Europe Tuberculosis (TB) Treatment Market Size by Application (2019-2024)

7.3.2 Europe Tuberculosis (TB) Treatment Market Size by Application (2025-2030)

7.3.3 Europe Tuberculosis (TB) Treatment Market Share by Application (2019-2030)

7.4 Europe Tuberculosis (TB) Treatment Market Size by Country

7.4.1 Europe Tuberculosis (TB) Treatment Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Tuberculosis (TB) Treatment Market Size by Country (2019-2024)

7.4.3 Europe Tuberculosis (TB) Treatment Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Tuberculosis (TB) Treatment Market Size (2019-2030)

8.2 China Tuberculosis (TB) Treatment Market Size by Type

8.2.1 China Tuberculosis (TB) Treatment Market Size by Type (2019-2024)

8.2.2 China Tuberculosis (TB) Treatment Market Size by Type (2025-2030)

8.2.3 China Tuberculosis (TB) Treatment Market Share by Type (2019-2030)

8.3 China Tuberculosis (TB) Treatment Market Size by Application

8.3.1 China Tuberculosis (TB) Treatment Market Size by Application (2019-2024)

8.3.2 China Tuberculosis (TB) Treatment Market Size by Application (2025-2030)

8.3.3 China Tuberculosis (TB) Treatment Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Tuberculosis (TB) Treatment Market Size (2019-2030)

9.2 Asia Tuberculosis (TB) Treatment Market Size by Type

9.2.1 Asia Tuberculosis (TB) Treatment Market Size by Type (2019-2024)

9.2.2 Asia Tuberculosis (TB) Treatment Market Size by Type (2025-2030)

9.2.3 Asia Tuberculosis (TB) Treatment Market Share by Type (2019-2030)

9.3 Asia Tuberculosis (TB) Treatment Market Size by Application

9.3.1 Asia Tuberculosis (TB) Treatment Market Size by Application (2019-2024)

9.3.2 Asia Tuberculosis (TB) Treatment Market Size by Application (2025-2030)

9.3.3 Asia Tuberculosis (TB) Treatment Market Share by Application (2019-2030)

9.4 Asia Tuberculosis (TB) Treatment Market Size by Region

9.4.1 Asia Tuberculosis (TB) Treatment Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Tuberculosis (TB) Treatment Market Size by Region (2019-2024)

9.4.3 Asia Tuberculosis (TB) Treatment Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Type

10.2.1 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Application

10.3.1 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Country

10.4.1 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Johnson & Johnson

11.1.1 Johnson & Johnson Company Details

11.1.2 Johnson & Johnson Business Overview

11.1.3 Johnson & Johnson Tuberculosis (TB) Treatment Introduction

11.1.4 Johnson & Johnson Revenue in Tuberculosis (TB) Treatment Business (2019-2024)

11.1.5 Johnson & Johnson Recent Developments

11.2 Otsuka Pharmaceutical Co., Ltd

11.2.1 Otsuka Pharmaceutical Co., Ltd Company Details

11.2.2 Otsuka Pharmaceutical Co., Ltd Business Overview

11.2.3 Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Introduction

11.2.4 Otsuka Pharmaceutical Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2019-2024)

11.2.5 Otsuka Pharmaceutical Co., Ltd Recent Developments

11.3 Macleods Pharmaceutical Ltd

11.3.1 Macleods Pharmaceutical Ltd Company Details

11.3.2 Macleods Pharmaceutical Ltd Business Overview

11.3.3 Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Introduction

11.3.4 Macleods Pharmaceutical Ltd Revenue in Tuberculosis (TB) Treatment Business (2019-2024)

11.3.5 Macleods Pharmaceutical Ltd Recent Developments

11.4 Dong-A ST Co., Ltd

11.4.1 Dong-A ST Co., Ltd Company Details

11.4.2 Dong-A ST Co., Ltd Business Overview

11.4.3 Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Introduction

11.4.4 Dong-A ST Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2019-2024)

11.4.5 Dong-A ST Co., Ltd Recent Developments

11.5 Lupin Ltd

11.5.1 Lupin Ltd Company Details

11.5.2 Lupin Ltd Business Overview

11.5.3 Lupin Ltd Tuberculosis (TB) Treatment Introduction

11.5.4 Lupin Ltd Revenue in Tuberculosis (TB) Treatment Business (2019-2024)

11.5.5 Lupin Ltd Recent Developments

11.6 Janssen Products, LP

11.6.1 Janssen Products, LP Company Details

11.6.2 Janssen Products, LP Business Overview

11.6.3 Janssen Products, LP Tuberculosis (TB) Treatment Introduction

11.6.4 Janssen Products, LP Revenue in Tuberculosis (TB) Treatment Business (2019-2024)

11.6.5 Janssen Products, LP Recent Developments

11.7 Mylan

11.7.1 Mylan Company Details

11.7.2 Mylan Business Overview

11.7.3 Mylan Tuberculosis (TB) Treatment Introduction

11.7.4 Mylan Revenue in Tuberculosis (TB) Treatment Business (2019-2024)

11.7.5 Mylan Recent Developments

11.8 Sanofi

11.8.1 Sanofi Company Details

11.8.2 Sanofi Business Overview

11.8.3 Sanofi Tuberculosis (TB) Treatment Introduction

11.8.4 Sanofi Revenue in Tuberculosis (TB) Treatment Business (2019-2024)

11.8.5 Sanofi Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Johnson & Johnson

Otsuka Pharmaceutical Co Ltd

Macleods Pharmaceutical Ltd

List of Tables

Table 1. Global Tuberculosis (TB) Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Isoniazid

Table 3. Key Players of Rifampin (Rifadin, Rimactane)

Table 4. Key Players of Ethambutol (Myambutol)

Table 5. Key Players of Pyrazinamide

Table 6. Global Tuberculosis (TB) Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Tuberculosis (TB) Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Tuberculosis (TB) Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Tuberculosis (TB) Treatment Market Share by Region (2019-2024)

Table 10. Global Tuberculosis (TB) Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Tuberculosis (TB) Treatment Market Share by Region (2025-2030)

Table 12. Tuberculosis (TB) Treatment Market Trends

Table 13. Tuberculosis (TB) Treatment Market Drivers

Table 14. Tuberculosis (TB) Treatment Market Challenges

Table 15. Tuberculosis (TB) Treatment Market Restraints

Table 16. Global Tuberculosis (TB) Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Tuberculosis (TB) Treatment Revenue Share by Players (2019-2024)

Table 18. Global Top Tuberculosis (TB) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Treatment as of 2023)

Table 19. Global Tuberculosis (TB) Treatment Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Tuberculosis (TB) Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Tuberculosis (TB) Treatment, Headquarters and Area Served

Table 22. Global Key Players of Tuberculosis (TB) Treatment, Product and Application

Table 23. Global Key Players of Tuberculosis (TB) Treatment, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Tuberculosis (TB) Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Tuberculosis (TB) Treatment Revenue Market Share by Type (2019-2024)

Table 27. Global Tuberculosis (TB) Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Tuberculosis (TB) Treatment Revenue Market Share by Type (2025-2030)

Table 29. Global Tuberculosis (TB) Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Tuberculosis (TB) Treatment Revenue Share by Application (2019-2024)

Table 31. Global Tuberculosis (TB) Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Tuberculosis (TB) Treatment Revenue Share by Application (2025-2030)

Table 33. North America Tuberculosis (TB) Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Tuberculosis (TB) Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Tuberculosis (TB) Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Tuberculosis (TB) Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Tuberculosis (TB) Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Tuberculosis (TB) Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Tuberculosis (TB) Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Tuberculosis (TB) Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Tuberculosis (TB) Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Tuberculosis (TB) Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Tuberculosis (TB) Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Tuberculosis (TB) Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Tuberculosis (TB) Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Tuberculosis (TB) Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Tuberculosis (TB) Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Tuberculosis (TB) Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Tuberculosis (TB) Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Tuberculosis (TB) Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Tuberculosis (TB) Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Tuberculosis (TB) Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Tuberculosis (TB) Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Tuberculosis (TB) Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Tuberculosis (TB) Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Tuberculosis (TB) Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Tuberculosis (TB) Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 65. Johnson & Johnson Company Details

Table 66. Johnson & Johnson Business Overview

Table 67. Johnson & Johnson Tuberculosis (TB) Treatment Product

Table 68. Johnson & Johnson Revenue in Tuberculosis (TB) Treatment Business (2019-2024) & (US$ Million)

Table 69. Johnson & Johnson Recent Developments

Table 70. Otsuka Pharmaceutical Co., Ltd Company Details

Table 71. Otsuka Pharmaceutical Co., Ltd Business Overview

Table 72. Otsuka Pharmaceutical Co., Ltd Tuberculosis (TB) Treatment Product

Table 73. Otsuka Pharmaceutical Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2019-2024) & (US$ Million)

Table 74. Otsuka Pharmaceutical Co., Ltd Recent Developments

Table 75. Macleods Pharmaceutical Ltd Company Details

Table 76. Macleods Pharmaceutical Ltd Business Overview

Table 77. Macleods Pharmaceutical Ltd Tuberculosis (TB) Treatment Product

Table 78. Macleods Pharmaceutical Ltd Revenue in Tuberculosis (TB) Treatment Business (2019-2024) & (US$ Million)

Table 79. Macleods Pharmaceutical Ltd Recent Developments

Table 80. Dong-A ST Co., Ltd Company Details

Table 81. Dong-A ST Co., Ltd Business Overview

Table 82. Dong-A ST Co., Ltd Tuberculosis (TB) Treatment Product

Table 83. Dong-A ST Co., Ltd Revenue in Tuberculosis (TB) Treatment Business (2019-2024) & (US$ Million)

Table 84. Dong-A ST Co., Ltd Recent Developments

Table 85. Lupin Ltd Company Details

Table 86. Lupin Ltd Business Overview

Table 87. Lupin Ltd Tuberculosis (TB) Treatment Product

Table 88. Lupin Ltd Revenue in Tuberculosis (TB) Treatment Business (2019-2024) & (US$ Million)

Table 89. Lupin Ltd Recent Developments

Table 90. Janssen Products, LP Company Details

Table 91. Janssen Products, LP Business Overview

Table 92. Janssen Products, LP Tuberculosis (TB) Treatment Product

Table 93. Janssen Products, LP Revenue in Tuberculosis (TB) Treatment Business (2019-2024) & (US$ Million)

Table 94. Janssen Products, LP Recent Developments

Table 95. Mylan Company Details

Table 96. Mylan Business Overview

Table 97. Mylan Tuberculosis (TB) Treatment Product

Table 98. Mylan Revenue in Tuberculosis (TB) Treatment Business (2019-2024) & (US$ Million)

Table 99. Mylan Recent Developments

Table 100. Sanofi Company Details

Table 101. Sanofi Business Overview

Table 102. Sanofi Tuberculosis (TB) Treatment Product

Table 103. Sanofi Revenue in Tuberculosis (TB) Treatment Business (2019-2024) & (US$ Million)

Table 104. Sanofi Recent Developments

Table 105. Research Programs/Design for This Report

Table 106. Key Data Information from Secondary Sources

Table 107. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Tuberculosis (TB) Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Tuberculosis (TB) Treatment Market Share by Type: 2023 VS 2030

Figure 3. Isoniazid Features

Figure 4. Rifampin (Rifadin, Rimactane) Features

Figure 5. Ethambutol (Myambutol) Features

Figure 6. Pyrazinamide Features

Figure 7. Global Tuberculosis (TB) Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Tuberculosis (TB) Treatment Market Share by Application: 2023 VS 2030

Figure 9. Active TB Case Studies

Figure 10. Latent TB Case Studies

Figure 11. Tuberculosis (TB) Treatment Report Years Considered

Figure 12. Global Tuberculosis (TB) Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Tuberculosis (TB) Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Tuberculosis (TB) Treatment Market Share by Region: 2023 VS 2030

Figure 15. Global Tuberculosis (TB) Treatment Market Share by Players in 2023

Figure 16. Global Top Tuberculosis (TB) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Treatment as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Tuberculosis (TB) Treatment Revenue in 2023

Figure 18. North America Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Tuberculosis (TB) Treatment Market Share by Type (2019-2030)

Figure 20. North America Tuberculosis (TB) Treatment Market Share by Application (2019-2030)

Figure 21. North America Tuberculosis (TB) Treatment Market Share by Country (2019-2030)

Figure 22. United States Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Tuberculosis (TB) Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 25. Europe Tuberculosis (TB) Treatment Market Share by Type (2019-2030)

Figure 26. Europe Tuberculosis (TB) Treatment Market Share by Application (2019-2030)

Figure 27. Europe Tuberculosis (TB) Treatment Market Share by Country (2019-2030)

Figure 28. Germany Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China Tuberculosis (TB) Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 35. China Tuberculosis (TB) Treatment Market Share by Type (2019-2030)

Figure 36. China Tuberculosis (TB) Treatment Market Share by Application (2019-2030)

Figure 37. Asia Tuberculosis (TB) Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 38. Asia Tuberculosis (TB) Treatment Market Share by Type (2019-2030)

Figure 39. Asia Tuberculosis (TB) Treatment Market Share by Application (2019-2030)

Figure 40. Asia Tuberculosis (TB) Treatment Market Share by Region (2019-2030)

Figure 41. Japan Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America Tuberculosis (TB) Treatment Market Share by Country (2019-2030)

Figure 51. Brazil Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries Tuberculosis (TB) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Johnson & Johnson Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2019-2024)

Figure 58. Otsuka Pharmaceutical Co., Ltd Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2019-2024)

Figure 59. Macleods Pharmaceutical Ltd Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2019-2024)

Figure 60. Dong-A ST Co., Ltd Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2019-2024)

Figure 61. Lupin Ltd Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2019-2024)

Figure 62. Janssen Products, LP Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2019-2024)

Figure 63. Mylan Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2019-2024)

Figure 64. Sanofi Revenue Growth Rate in Tuberculosis (TB) Treatment Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions